These findings indicated that BCA-induced reduced Akt activity plays a vital role in inhibiting the levels of some glycolytic enzymes (Glut-1, HK2, and LDHA) and leads to reduced aerobic glycolysis in glioma cells. The gene discussed is SLC2A1; the disease is central nervous system cancer.